Patent Assignment
Reel/Frame 067309/0049
Assignment of Assignor's Interest
Recorded: 2024-05-03
Pages: 2
Assignor
BRIDGEBIO SERVICES INC.
Executed: 2024-04-18
Assignee
PORTAL THERAPEUTICS, INC.
3160 PORTER DRIVE, SUITE 250, PALO ALTO, CALIFORNIA, 94304
Covered Property
(1)
Amido Pyrido[3,4-B]Indole-1,4-Dione Compounds for Treatment of Porphyrias
Application:
63/498,362 →
Related Assignments
(8)
Other recorded transfers of the patent in this record — the chain of ownership.
Security Interest
Jan 17, 2024
From: CALCILYTIX THERAPEUTICS INC.; ADRENAS THERAPEUTICS INC.; PHOENIX TISSUE REPAIR, INC.; NAVIRE PHARMA, INC.
To: BLUE OWL CAPITAL CORPORATION, AS ADMINISTRATIVE AGENT
Reel/Frame 066342/0154 →
Security Interest
Jan 19, 2024
From: BRIDGEBIO PHARMA, INC.; QED THERAPEUTICS, INC.; EIDOS THERAPEUTICS, INC.; THERAS, INC.
To: BLUE OWL CAPITAL CORPORATION, AS ADMINISTRATIVE AGENT
Reel/Frame 066355/0126 →
Assignment of Assignor's Interest
May 3, 2024
From: BACHAND, BENOIT; LI, SHIGUANG
To: ZAMBONI CHEM SOLUTIONS INC.
Reel/Frame 067307/0743 →
Assignment of Assignor's Interest
May 3, 2024
From: ZAMBONI CHEM SOLUTIONS INC.
To: PORTAL THERAPEUTICS, INC.
Reel/Frame 067308/0300 →
Assignment of Assignor's Interest
May 3, 2024
From: HUANG, EDMOND; PAULL, MORGAN; BROWER, KARA; SINHA, UMA
To: BRIDGEBIO SERVICES INC.
Reel/Frame 067308/0780 →
Assignment of Assignor's Interest
May 3, 2024
From: ZAMBONI, ROBERT
To: BRIDGEBIO PHARMA CANADA, ULC
Reel/Frame 067309/0253 →
Assignment of Assignor's Interest
May 3, 2024
From: BRIDGEBIO PHARMA CANADA, ULC
To: PORTAL THERAPEUTICS, INC.
Reel/Frame 067309/0311 →
Release of Security Interest
Aug 16, 2024
From: BLUE OWL CAPITAL CORPORATION, AS ADMINISTRATIVE AGENT
To: PORTAL THERAPEUTICS, INC.; SUB21, INC.; BRIDGEBIO PHARMA, INC.
Reel/Frame 068317/0804 →